drospirenone has been researched along with Bleeding Between Periods in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (10.00) | 29.6817 |
2010's | 8 (80.00) | 24.3611 |
2020's | 1 (10.00) | 2.80 |
Authors | Studies |
---|---|
Achilles, SL; Apolikhina, I; Bouchard, C; Chen, MJ; Creinin, MD; Foidart, JM; Jensen, JT; Jost, M; Kaunitz, AM; Piltonen, T; Suturina, L; Westhoff, CL; Weyers, S; Zatik, J | 1 |
Colli, E; Palacios, S; Regidor, PA | 2 |
Cheng, W; Fu, Y; Li, L; Mi, W; Sun, L; Wang, J; Xie, S; Zhang, H; Zhang, J | 1 |
Drouin, D; Duijkers, IJ; Heger-Mahn, D; Skouby, S | 1 |
Apter, D; Beekman, L; Coelingh Bennink, HJ; Foidart, JM; Maillard, C; Mawet, M; Zimmerman, Y | 1 |
Burkman, RT; Fisher, AC; Kaunitz, AM; LaGuardia, KD | 1 |
de Melo, NR; Machado, RB; Maia, H | 1 |
El-Sherbiny, WS; Mohamed, AM; Mostafa, WA | 1 |
Korver, T; Mansour, D; Melis, GB; Sommer, W; Sundström-Poromaa, I; Taneepanichskul, S; Verhoeven, C; Weisberg, E | 1 |
10 trial(s) available for drospirenone and Bleeding Between Periods
Article | Year |
---|---|
Pooled analysis of two phase 3 trials evaluating the effects of a novel combined oral contraceptive containing estetrol/drospirenone on bleeding patterns in healthy women.
Topics: Adolescent; Adult; Androstenes; Contraceptives, Oral, Combined; Estetrol; Estrogens; Female; Humans; Metrorrhagia; Middle Aged; Uterine Hemorrhage; Young Adult | 2022 |
A multicenter, double-blind, randomized trial on the bleeding profile of a drospirenone-only pill 4 mg over nine cycles in comparison with desogestrel 0.075 mg.
Topics: Adolescent; Adult; Androstenes; Contraception; Contraceptives, Oral; Desogestrel; Double-Blind Method; Female; Humans; Metrorrhagia; Middle Aged; Young Adult | 2019 |
Multicenter, phase III trials on the contraceptive efficacy, tolerability and safety of a new drospirenone-only pill.
Topics: Adult; Androstenes; Contraceptives, Oral; Female; Humans; Hyperkalemia; Metrorrhagia; Pregnancy; Pregnancy Rate; Prospective Studies; Pulmonary Embolism; Treatment Failure; Venous Thrombosis; Young Adult | 2019 |
[Efficacy and safety of a combined oral contraceptive containing drospirenone 3 mg and ethinylestradiol 20 µg in the treatment of premenstrual dysphoric disorder: a randomized, double blind placebo-controlled study].
Topics: Androstenes; Contraceptives, Oral; Contraceptives, Oral, Combined; Double-Blind Method; Ethinyl Estradiol; Female; Humans; Menorrhagia; Metrorrhagia; Premenstrual Dysphoric Disorder; Premenstrual Syndrome; Safety; Severity of Illness Index; Treatment Outcome | 2014 |
A randomised study comparing the effect on ovarian activity of a progestogen-only pill (POP) containing desogestrel and a new POP containing drospirenone in a 24/4 regimen.
Topics: Adult; Androstenes; Cervix Mucus; Contraceptives, Oral, Synthetic; Desogestrel; Endometrium; Estradiol; Female; Healthy Volunteers; Humans; Metrorrhagia; Ovarian Follicle; Ovulation Inhibition; Permeability; Progesterone; Young Adult | 2015 |
Bleeding pattern and cycle control with estetrol-containing combined oral contraceptives: results from a phase II, randomised, dose-finding study (FIESTA).
Topics: Androstenes; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Estetrol; Estradiol; Female; Humans; Levonorgestrel; Metrorrhagia; Nandrolone | 2016 |
Cycle control with a 21-day compared with a 24-day oral contraceptive pill: a randomized controlled trial.
Topics: Adult; Androstenes; Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Metrorrhagia; Mineralocorticoid Receptor Antagonists; Norgestrel; Young Adult | 2009 |
Bleeding patterns and menstrual-related symptoms with the continuous use of a contraceptive combination of ethinylestradiol and drospirenone: a randomized study.
Topics: Adult; Amenorrhea; Analysis of Variance; Androstenes; Contraceptives, Oral, Combined; Drug Administration Schedule; Ethinyl Estradiol; Female; Humans; Intention to Treat Analysis; Longitudinal Studies; Metrorrhagia; Patient Satisfaction; Prospective Studies; Quality of Life; Statistics, Nonparametric; Treatment Outcome; Women's Health | 2010 |
Combined contraceptive ring versus combined oral contraceptive (30-μg ethinylestradiol and 3-mg drospirenone).
Topics: Acne Vulgaris; Adolescent; Adult; Affective Symptoms; Androstenes; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Leukorrhea; Libido; Lipoproteins, LDL; Metrorrhagia; Vaginitis; Weight Gain; Young Adult | 2011 |
Efficacy and tolerability of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol in a 24/4 regimen, in comparison to an oral contraceptive containing ethinylestradiol and drospirenone in a 21/7 regimen.
Topics: Acne Vulgaris; Adolescent; Adult; Androstenes; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Estradiol; Estrogens; Ethinyl Estradiol; Female; Humans; Megestrol; Menstrual Cycle; Metrorrhagia; Middle Aged; Mineralocorticoid Receptor Antagonists; Norpregnadienes; Pregnancy; Pregnancy Rate; Substance Withdrawal Syndrome; Young Adult | 2011 |